Treatment

JNJ-101556143 Formulation 2 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1, PHASE2
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
This study is testing a new drug, HLD-0915, for men with advanced prostate cancer that has stopped responding to standard treatments. It aims to see if the drug is safe and effective in slowing down the cancer's growth.
For: Metastatic Prostate Cancer
United States · United Kingdom